{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:56:06Z","timestamp":1794279366077,"version":"4.9.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["K112301924"],"award-info":[{"award-number":["K112301924"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jocn.2026.112143","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:01:15Z","timestamp":1781456475000},"page":"112143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Machine learning-based mri radiomics for predicting bevacizumab response in peritumoral brain edema of glioblastoma"],"prefix":"10.1016","volume":"152","author":[{"given":"Qilong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jocn.2026.112143_b0005","doi-asserted-by":"crossref","first-page":"40253","DOI":"10.1038\/s41598-025-24151-z","article-title":"Pathological changes and aquaporin-4 expression after bevacizumab treatment of traumatic penumbra in the rat brain","volume":"15","author":"Lin","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.jocn.2026.112143_b0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00401-009-0541-0","article-title":"Pathology and new players in the pathogenesis of brain edema","volume":"118","author":"Nag","year":"2009","journal-title":"Acta Neuropathol. (Berl.)"},{"issue":"1","key":"10.1016\/j.jocn.2026.112143_b0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12943-019-0950-1","article-title":"Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues","volume":"18","author":"Zhuang","year":"2019","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.jocn.2026.112143_b0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s10014-017-0284-x","article-title":"Bevacizumab for malignant gliomas: current indications, mechanisms of action and resistance, and markers of response","volume":"34","author":"Tamura","year":"2017","journal-title":"Brain Tumor Pathol."},{"issue":"5","key":"10.1016\/j.jocn.2026.112143_b0025","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.4103\/0028-3886.271242","article-title":"The safety and efficacy of bevacizumab for radiosurgery - induced steroid - resistant brain edema; not the last part in the ship of theseus","volume":"67","author":"Tripathi","year":"2019","journal-title":"Neurol. India"},{"issue":"1","key":"10.1016\/j.jocn.2026.112143_b0030","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/JS9.0000000000001969","article-title":"Intraoperative goal-directed fluid management and postoperative brain edema in patients having high-grade gliomas resections: a randomized trial","volume":"111","author":"Liu","year":"2025","journal-title":"Int. J. Surg."},{"issue":"9","key":"10.1016\/j.jocn.2026.112143_b0035","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/phar.2310","article-title":"Bevacizumab use and the risk of arterial and venous thromboembolism in patients with high-grade gliomas: a nested case-control study","volume":"39","author":"Lee","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jocn.2026.112143_b0040","unstructured":"\u2018Predicting the efficacy of bevacizumab on peritumoral edema based on imaging features and machine learning - PubMed\u2019. Accessed: May 25, 2026. [Online]. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/40341749\/."},{"issue":"2","key":"10.1016\/j.jocn.2026.112143_b0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/2042098611430109","article-title":"Risks and benefits with bevacizumab: evidence and clinical implications","volume":"3","author":"Kurkjian","year":"2012","journal-title":"Ther. Adv. Drug Saf."},{"issue":"21","key":"10.1016\/j.jocn.2026.112143_b0050","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","author":"van Griethuysen","year":"2017","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.jocn.2026.112143_b0055","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s00234-025-03657-3","article-title":"Can machine learning be a reliable tool for predicting hematoma progression following traumatic brain injury? A systematic review and meta-analysis","volume":"67","author":"Mohammadzadeh","year":"2025","journal-title":"Neuroradiology"},{"issue":"2","key":"10.1016\/j.jocn.2026.112143_b0060","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12020-025-04351-3","article-title":"Using machine learning to predict remission after surgery for pituitary adenoma: a systematic review and meta-analysis","volume":"90","author":"Mohammadzadeh","year":"2025","journal-title":"Endocrine"},{"key":"10.1016\/j.jocn.2026.112143_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2025.108762","article-title":"Can we rely on machine learning algorithms as a trustworthy predictor for recurrence in high-grade glioma? A systematic review and meta-analysis","volume":"249","author":"Mohammadzadeh","year":"2025","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jocn.2026.112143_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1587745","article-title":"Radiomics features from the peritumoral region can be associated with the epilepsy status of glioblastoma patients","volume":"15","author":"Yun","year":"2025","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.jocn.2026.112143_b0075","doi-asserted-by":"crossref","first-page":"628.e17","DOI":"10.1016\/j.crad.2021.03.019","article-title":"Machine learning-based radiomic evaluation of treatment response prediction in glioblastoma","volume":"76","author":"Patel","year":"2021","journal-title":"Clin. Radiol."},{"issue":"11","key":"10.1016\/j.jocn.2026.112143_b0080","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00234-019-02255-4","article-title":"Radiomics in peritumoral non-enhancing regions: fractional anisotropy and cerebral blood volume improve prediction of local progression and overall survival in patients with glioblastoma","volume":"61","author":"Kim","year":"2019","journal-title":"Neuroradiology"},{"issue":"6","key":"10.1016\/j.jocn.2026.112143_b0085","doi-asserted-by":"crossref","DOI":"10.1148\/ryai.2020190168","article-title":"Tumor habitat-derived radiomic features at pretreatment MRI that are prognostic for progression-free survival in glioblastoma are associated with key morphologic attributes at histopathologic examination: a feasibility study","volume":"2","author":"Verma","year":"2020","journal-title":"Radiol. Artif. Intell."},{"issue":"1","key":"10.1016\/j.jocn.2026.112143_b0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.6004\/jnccn.2023.0002","article-title":"NCCN Guidelines\u00ae insights: central nervous system cancers, version 2.2022","volume":"21","author":"Horbinski","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw. JNCCN"},{"issue":"6","key":"10.1016\/j.jocn.2026.112143_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0326361","article-title":"Multimodal MRI radiomics based on habitat subregions of the tumor microenvironment for predicting risk stratification in glioblastoma","volume":"20","author":"Wang","year":"2025","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.jocn.2026.112143_b0100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11060-025-05037-6","article-title":"Combined peritumoral radiomics and clinical features predict 12-month progression free survival in glioblastoma","volume":"174","author":"Yun","year":"2025","journal-title":"J. Neurooncol."},{"issue":"8","key":"10.1016\/j.jocn.2026.112143_b0105","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3174\/ajnr.A7591","article-title":"Stable and discriminatory radiomic features from the tumor and its habitat associated with progression-free survival in glioblastoma: a multi-institutional study","volume":"43","author":"Verma","year":"2022","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"6","key":"10.1016\/j.jocn.2026.112143_b0110","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1016\/j.acra.2026.01.042","article-title":"Intratumoral and peritumoral habitat radiomics on multiparametric mri for preoperative prediction of 1-year progression-free survival status in glioblastoma: a multicenter study","volume":"33","author":"Zhao","year":"2026","journal-title":"Acad. Radiol."},{"issue":"1","key":"10.1016\/j.jocn.2026.112143_b0115","doi-asserted-by":"crossref","first-page":"43932","DOI":"10.1038\/s41598-025-27711-5","article-title":"Radiomics-based quantification of tumor infiltration in the non-enhancing peritumoral region on postoperative MRI is associated with survival in glioblastoma","volume":"15","author":"Cepeda","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jocn.2026.112143_b0120","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.70198","article-title":"Predictive value of machine learning models for cerebral edema risk in stroke patients: a meta-analysis","volume":"15","author":"Deng","year":"2025","journal-title":"Brain Behav."},{"key":"10.1016\/j.jocn.2026.112143_b0125","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1200\/CCI.20.00072","article-title":"Machine learning in oncology: methods, applications, and challenges","volume":"4","author":"Bertsimas","year":"2020","journal-title":"JCO Clin. Cancer Inform."},{"issue":"2","key":"10.1016\/j.jocn.2026.112143_b0130","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4274\/dir.2023.221764","article-title":"Radiomics analysis for predicting malignant cerebral edema in patients undergoing endovascular treatment for acute ischemic stroke","volume":"29","author":"Wen","year":"2023","journal-title":"Diagn. Interv. Radiol."},{"issue":"6","key":"10.1016\/j.jocn.2026.112143_b0135","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/RCT.0000000000001510","article-title":"Radiogenomic analysis of vascular endothelial growth factor in patients with glioblastoma","volume":"47","author":"Zheng","year":"2023","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.jocn.2026.112143_b0140","doi-asserted-by":"crossref","unstructured":"J. Cai et al., \u2018A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy\u2019, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res., vol. 26, no. 20, pp. 5438\u20135447, Oct. 2020, doi: 10.1158\/1078-0432.CCR-20-1264.","DOI":"10.1158\/1078-0432.CCR-20-1264"},{"issue":"4","key":"10.1016\/j.jocn.2026.112143_b0145","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3174\/ajnr.A4567","article-title":"Radiologic features and expression of vascular endothelial growth factor stratify survival outcomes in patients with glioblastoma","volume":"37","author":"Wang","year":"2016","journal-title":"AJNR Am. J. Neuroradiol."}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826002948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826002948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T14:24:48Z","timestamp":1793802288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586826002948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":29,"alternative-id":["S0967586826002948"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2026.112143","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Machine learning-based mri radiomics for predicting bevacizumab response in peritumoral brain edema of glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2026.112143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112143"}}